Search research articles
Contact Us
Filters
Showing results (211-220 of 232) with videos related to
Page
of 24
Sort By:
Annals of Surgical Oncology
|
August 29, 2014
Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
Marianne Schmid, Michael Rink, Miriam Traumann, et al.
Trials
|
November 13, 2024
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial
Rouvier Al-Monajjed, Peter Albers, Johanna Droop, et al.
European Urology
|
October 30, 2025
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry
Madeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, et al.
European Urology
|
June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial
Rouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
European Urology
|
October 20, 2023
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial
Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al.
Nature Communications
|
June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
Rouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
European Urology Oncology
|
November 11, 2025
Value of Additional Systematic Cores During Magnetic Resonance Imaging-guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE Trial
Rouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
European Urology
|
March 30, 2013
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group
Caroline M Moore, Veeru Kasivisvanathan, Scott Eggener, et al.
European Urology Oncology
|
June 1, 2026
MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial
Matthias Boschheidgen, Rouvier Al-Monajjed, Heinz-Peter Schlemmer, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 232) with videos related to
Sort By:
Page
of 24
Annals of Surgical Oncology
|
August 29, 2014
Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
Marianne Schmid, Michael Rink, Miriam Traumann, et al.
Trials
|
November 13, 2024
PRO-P: evaluating the effect of electronic patient-reported outcome measures monitoring compared with standard care in prostate cancer patients undergoing surgery-study protocol for a randomized controlled trial
Rouvier Al-Monajjed, Peter Albers, Johanna Droop, et al.
European Urology
|
October 30, 2025
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry
Madeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, et al.
European Urology
|
June 3, 2025
Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging-targeted Biopsy in the PROBASE Trial
Rouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.
European Urology
|
October 20, 2023
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial
Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al.
Nature Communications
|
June 14, 2016
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
Rouven Hoefflin, Bernd Lahrmann, Gregor Warsow, et al.
European Urology Oncology
|
November 11, 2025
Value of Additional Systematic Cores During Magnetic Resonance Imaging-guided Targeted Biopsy in Prostate Cancer Screening for Young Men: Results from the PROBASE Trial
Rouvier Al-Monajjed, Matthias Boschheidgen, Jale Lakes, et al.
European Urology
|
March 30, 2013
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group
Caroline M Moore, Veeru Kasivisvanathan, Scott Eggener, et al.
European Urology Oncology
|
June 1, 2026
MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial
Matthias Boschheidgen, Rouvier Al-Monajjed, Heinz-Peter Schlemmer, et al.
Page
of 24